First Horizon Advisors, Inc. Intellia Therapeutics, Inc. Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,674 shares of NTLA stock, worth $38,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,674

Previous 2,604 2.69%

Holding current value

$38,238

Previous $58,000 6.9%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$19.72 - $27.36 $1,380 - $1,915	70 Added 2.69%	2,674 $54,000
Q2 2024 Jul 19, 2024	BUY	$20.02 - $27.22 $9,449 - $12,847	472 Added 22.14%	2,604 $58,000
Q1 2024 Apr 26, 2024	BUY	$23.82 - $32.8 $4,192 - $5,772	176 Added 9.0%	2,132 $58,000
Q4 2023 Feb 06, 2024	SELL	$23.16 - $32.34 $8,986 - $12,547	-388 Reduced 16.55%	1,956 $59,000
Q3 2023 Oct 27, 2023	SELL	$31.62 - $45.78 $25,485 - $36,898	-806 Reduced 25.59%	2,344 $74,000
Q2 2023 Aug 03, 2023	SELL	$34.58 - $46.03 $6,916 - $9,206	-200 Reduced 5.97%	3,150 $128,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $166 - $224	-5 Reduced 0.15%	3,350 $124,000
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $2,656 - $5,015	80 Added 2.44%	3,355 $117,000
Q3 2022 Nov 09, 2022	SELL	$53.92 - $71.7 $12,725 - $16,921	-236 Reduced 6.72%	3,275 $183,000
Q2 2022 Aug 02, 2022	BUY	$38.49 - $76.21 $135,138 - $267,573	3,511 New	3,511 $181,000
Q1 2022 May 10, 2022	SELL	$58.27 - $118.99 $77,324 - $157,899	-1,327 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$100.76 - $138.36 $10,680 - $14,666	106 Added 8.68%	1,327 $156,000
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $47,917 - $63,994	-362 Reduced 22.87%	1,221 $163,000
Q3 2021 Nov 09, 2021	BUY	$132.37 - $176.78 $77,568 - $103,593	586 Added 58.78%	1,583 $212,000
Q2 2021 Aug 09, 2021	SELL	$60.88 - $161.91 $1,339 - $3,562	-22 Reduced 2.16%	997 $161,000
Q1 2021 May 11, 2021	BUY	$46.59 - $83.68 $47,475 - $85,269	1,019 New	1,019 $81,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.09B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Intellia Therapeutics, Inc. Transaction History